Phase II study of topotecan and amrubicin for metastatic or relapsed small-cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 08 Mar 2011
At a glance
- Drugs Amrubicin (Primary) ; Topotecan (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 08 Mar 2011 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 05 Jun 2009 New trial record.